CHRNA7 and Cowden syndrome 1: Our previous studies showed that Ani could decrease on-site mortality in CS through modest reduction (−10%∼-20%) of serum potassium, and such effect was mediated by indirect activation of α7nAChR (Fan et al., 2016), which was verified with MLA, selective antagonist of α7nAChR, in the present study.